Improvement of a low pH antigen-antibody dissociation procedure for ELISA measurement of circulating anti-Aβ antibodies by Li, Qingyou et al.
BioMed  Central
Page 1 of 11
(page number not for citation purposes)
BMC Neuroscience
Open Access Research article
Improvement of a low pH antigen-antibody dissociation procedure 
for ELISA measurement of circulating anti-Aβ antibodies
Qingyou Li1, Marcia Gordon1, Chuanhai Cao2,3, Kenneth E Ugen2 and 
Dave Morgan*1
Address: 1Alzheimer's Research Laboratory, Department of Molecular Pharmacology and Physiology, University of South Florida, Tampa, FL 
33612-4799, USA, 2Department of Molecular Medicine, University of South Florida, Tampa, FL 33612-4799, USA and 3Byrd Institute for 
Alzheimer's Disease, Tampa, FL 33612-4799, USA
Email: Qingyou Li - qli@hsc.usf.edu; Marcia Gordon - mgordon@hsc.usf.edu; Chuanhai Cao - ccao@byrdinstitute.org; 
Kenneth E Ugen - kugen@hsc.usf.edu; Dave Morgan* - dmorgan@hsc.usf.edu
* Corresponding author    
Abstract
Background: Prior work from our group found that acid dissociation (pH 2.5 incubation) of serum from APP
transgenic mice vaccinated against Aβ increased the apparent anti-Aβ titers, suggesting antibody masking by
antigen in the ELISA assay. Subsequently, we found that pH 2.5 incubation of serum from unvaccinated non-
transgenic mice showed antibody binding to Aβ1–42, but no increase when other proteins, including shorter Aβ
peptides, coated the ELISA plate. To investigate further the effects of low pH incubation on apparent anti-Aβ1–
42 signals, we examined normal sera from nonTg unvaccinated mice, nonTg mice vaccinated with Aβ peptide (to
produce authentic anti-Aβ antibodies) or a monoclonal antibody against Aβ (6E10) using competitive-inhibition
ELISA and Aβ epitope mapping assays. In addition, we examined use of a less stringent low pH procedure at pH
3.5, to ascertain if it had the same effects as the pH 2.5 procedure.
Results: We believe there are three distinct effects of pH 2.5 incubation.; A) an artifactual increase in binding to
full length Aβ by mouse immunoglobulin which has low affinity for Aβ, B) an inactivation of anti-Aβ antibodies that
is time dependent and C) unmasking of high affinity anti-Aβ antibodies when high levels of circulating Aβ is present
in APP transgenic mice. All three reactions can interact to produce the final ELISA signal. Incubation of sera from
unvaccinated nonTg mice at pH 2.5 enhanced ELISA signals by process A. Conversely, pH 2.5 incubation of sera
from vaccinated nonTg mice with caused a time dependent reduction of antibody signal by process B (overcoming
the increase caused by A). The artifactual anti-Aβ ELISA signal enhanced by pH 2.5 incubation of normal mouse
sera could not be effectively competed by low to moderate concentrations of Aβ, nor bind to shorter Aβ peptides
in a manner similar to authentic anti-Aβ antibodies. Incubation of mouse sera at pH 3.5 caused neither an apparent
increase in anti-Aβ ELISA signal, nor an inactivation of the ELISA signals resulting from either vaccination or
monoclonal antibodies. However, incubation at pH 3.5 was able to completely reverse the reduction in ELISA
signal caused by Aβ complexing with antibodies in sera from vaccinated mice or monoclonal anti-Aβ antibodies.
Conclusion: Incubation at pH 3.5 is sufficient to dissociate Aβ bound to anti-Aβ antibodies without producing
artifactual increases in the signal, or inactivating authentic antibody binding. Thus, use of pH 3.5 is a considerable
improvement over pH 2.5 incubation for unmasking anti-Aβ antibodies in ELISA assays to measure antibodies in
APP transgenic mouse sera.
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Background
It has been well documented that active immunization of
transgenic mice against the Aβ peptide can dramatically
reduce the deposition of amyloid [1] and improve learn-
ing and memory behavior in amyloid depositing trans-
genic mice[2,3]. However, the anti-Aβ antibody response
to vaccination of amyloid precursor protein (APP) trans-
genic mice appeared lower than in nontransgenic (nonTg)
littermates [4-6]. It has also been reported in some studies
that patients with Alzheimer disease (AD) have lower lev-
els of serum anti-Aβ antibodies than healthy age-matched
individuals [7,8], although others report no change [9] or
an increase [10].
This impaired antibody response may result from self tol-
erance in the APP transgenic mice, or absorption of the
serum antibody by circulating Aβ, which interferes with
antibody binding to Aβ coated ELISA plates (these are not
mutually exclusive). This latter explanation was sup-
ported by our prior work, where acid dissociation of
serum increased the apparent anti-Aβ antibody titer in
vaccinated APP transgenic mice [5]. Subsequently, we
unexpectedly found that the pH 2.5 dissociation proce-
dure also enhanced ELISA signals against Aβ1–42 in nor-
mal sera from nonTg unvaccinated mice. This suggested
that either a) normal mice have measurable anti-Aβ anti-
body titers that are masked by the low levels of circulating
murine Aβ or b) pH 2.5 incubation produces nonspecific
interactions between IgG and human Aβ1–42.
We have performed over 100 experiments in the last 3
years in order to identify which of these options is correct.
Our data now convince us A) pH 2.5 incubation does pro-
duce an artifactual association between IgG and full
length Aβ that is not due to typical antigen-antibody inter-
actions. In addition, we find that B) pH 2.5 incubation
also causes inactivation of authentic anti-Aβ antibodies
formed by vaccination. Finally, C) the low pH incubation
can unmask antibody bound to Aβ in circulation. Our
prior data are now explained in terms of all three events
occurring simultaneously. In addition, we demonstrate
that use of pH 3.5 instead of pH 2.5 can eliminate the arti-
factual binding and the antibody inactivation, while
retaining the antibody-antigen dissociation required to
assess the true antibody titers in serum.
Results
An increased anti-Aβ ELISA signal in sera from vaccinated 
transgenic mice with preincubation at pH 2.5 is also found 
in sera from nonTg unvaccinated mice
As observed previously, preincubation at pH 2.5 increases
the ELISA signal against Aβ1–42 when sera are taken from
APP transgenic mice that have been vaccinated against the
Aβ peptide (fig 1A). This enhanced signal was not
observed when other proteins or PBS were used to coat the
ELISA plate. We had interpreted this as indicating that the
low pH incubation dissociated antigen antibody com-
plexes formed in the serum of vaccinated mice overpro-
ducing Aβ (due to APP transgenesis). However, when we
performed the same pH 2.5 preincubation using normal
sera from nonTg mice (thus not overproducing the Aβ
peptide) who had never been vaccinated against Aβ (thus,
presumed to have very low anti-Aβ titers), we observed a
similar, albeit smaller, increase in the apparent anti-Aβ
titer (fig. 1B; note difference in Y axis values). Moreover,
this also was specific for Aβ1–42 relative to other proteins.
This latter signal we now believe is due to the artifactual
binding of mouse immunoglobulin to Aβ1–42 after incu-
bation at pH 2.5 (process A).
pH 2.5 induced artifactual anti-Aβ ELISA signal appears 
due to IgG rather than other serum proteins
In our prior dissociation study, the detection (secondary)
antibody was directed against whole-mouse IgG (Sigma,
product # A 4416). There is some potential for this detec-
tion antibody to react with other Ig classes such as IgM or
IgA. To address whether the enhanced ELISA signal from
nonTg unvaccinated mice after acid dissociation is specific
for IgG, we tested a more specific anti-mouse IgG γ-chain
detection antibody (Sigma, product# A 3673). The data
showed the ELISA signal detected by anti-mouse IgG γ
chain antibody was the same as detected by anti-whole
IgG antisera (fig. 2A). In addition, IgG purified from
nonTg unvaccinated mice using ImmunoPure (protein A/
G) IgG purification Kit retained the enhanced signal
towards Aβ on ELISA plates when incubated at pH 2.5.
(fig. 2B). These data indicate that artifactual pH 2.5
induced anti-Aβ ELISA signal appears associated with IgG.
Duration of low pH exposure differentially affects anti-Aβ 
ELISA signals in sera from unvaccinated mice compared to 
vaccinated mice
The sera from unvaccinated nonTg mice and nonTg mice
vaccinated against Aβ were exposed to dissociation buffer
pH at 2.5 for 5, 20, 30, 90 and 120 minutes. The data
showed that the ELISA signal of unvaccinated mice (fig.
3A) increased in a time dependent manner when the sera
were preincubated at pH 2.5. However, in vaccinated mice
which have authentic anti-Aβ antibodies, the antiserum
titers raised against human Aβ1–42 peptide were
decreased in a time dependent fashion (fig. 3B; also note
the different Y axes between the two figures) Thus in the
absence of authentic anti-Aβ antibody (3A), low pH arti-
fact (process A) is the only process active and increases the
apparent anti-Aβ titer, while in the presence of authentic
antibody (3B) the pH 2.5 exposure inactivates antibody
(process B) and this overcomes any artifactual increase
present in the sera.BMC Neuroscience 2007, 8:22 http://www.biomedcentral.com/1471-2202/8/22
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Low pH induced artifactual ELISA signals only bind to full 
length Aβ; Authentic anti-Aβ antibodies detect both full 
length Aβ and N terminal fragments
An epitope mapping study was performed to test if the Aβ
domain specificity of the artifactual ELISA signals induced
by pH 2.5 exposure differs from the domain specificity of
authentic anti-Aβ antibody. ELISA plates were coated with
full length sequence human Aβ1–42, N terminal human
Aβ1–16, C terminal human Aβ29–40, and mixture of
short human Aβ peptides as indicated on the x-axis of Fig
4. Sera from unvaccinated nonTg mice had low anti-Aβ
signals with a pH 7 incubation, but an increased signal
when incubated at pH 2.5. This elevation was largely spe-
cific for the full length peptide, and the signals found after
pH 2.5 for other Aβ peptides or their combinations were
no different than the signals seen with PBS (fig. 4A; there
is also a small artifactual ELISA signal found against the
plate with low pH incubation). When examining sera
from mice vaccinated against Aβ (thus having authentic
anti-Aβ antibodies) the low pH incubation actually
reduced the apparent anti-Aβ titer due to inactivation
(process B; fig 3B). Moreover, only ELISA plates contain-
ing Aβ1–16 bound the antibodies, consistent with work
from our group and others that the predominant epitope
for anti-Aβ vaccines is in the N terminal domain [11]. The
epitope specificity of the sera from vaccinated mice was
similar to that obtained with a monoclonal anti-Aβ anti-
body (6E10) directed against the N terminal domain (Fig
4c), again only associating when Aβ1–16 or 1–42 was
bound to the plate. Thus, the artifactual binding caused by
low pH incubation of normal mouse serum does not bind
shorter Aβ peptides, unlike authentic anti-Aβ antibodies.
pH 2.5 incubation induced artifactual anti-Aβ ELISA signal 
has a lower affinity for Aβ than authentic anti-Aβ 
antibodies in competition assays
To estimate the affinity of Aβ for the binding found after
pH 2.5 dissociation, a competitive inhibition ELISA study
was performed. Serum samples were incubated with
increasing concentrations of the Aβ peptide before addi-
tion to the ELISA plate. When normal sera from nonTg
unvaccinated mice were tested, the increased signal
Incubation at pH 2.5 induced increase in anti-Aβ ELISA signal is present not only in sera from vaccinated mice, but also  untreated mice Figure 1
Incubation at pH 2.5 induced increase in anti-Aβ ELISA signal is present not only in sera from vaccinated mice, but also 
untreated mice. Sera were collected from APP transgenic mice vaccinated (Vax +) with Aβ1–42 (panel A) and nonTg unvacci-
nated (Vax -) mice (panel B; normal serum), preincubated with dissociation buffer at either pH 7 (open bars) or pH 2.5 (solid 
bars) at room temperature for 20 minutes and centrifuged through 10,000 MW filters, brought to neutral pH and reconsti-
tuted to the original serum dilution volume. The sera were then incubated on ELISA plates coated with one of the following at 
5 μg/ml; human Aβ1–42, phosphate buffered saline (PBS; a "no protein" control), bovine serum albumin (BSA), recombinant 
alpha-synuclein (a-SYN) or Aβ peptide amino acids 11–20. ELISA assays were completed as described in methods and the opti-
cal density (OD) at 450 nm used to estimate the amount of antibody binding to the ELISA plate. Note different Y-axis scales in 
panels A and B. Results are presented as mean ± SEM. ** P < 0.001 compared to pH 7.0.
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caused by incubation at pH 2.5 was unaffected by compe-
tition until Aβ concentrations were at 100 μg/ml, and
even then the abrogation of signal was incomplete (fig
5A). In sera from vaccinated nonTg mice, incubation at
pH 2.5 reduced the anti-Aβ ELISA signal (due to the inac-
tivation process B), and this remaining signal was effec-
tively competed at Aβ1–42 concentrations of 1 μg/ml and
higher (fig 5B). These data indicated that the authentic
anti-Aβ antibodies have at least 100 fold greater affinity
for Aβ than the artifactual signal found after incubation at
pH 2.5.
Incubation at pH 3.5 avoids both the artifactual ELISA 
signal and the inactivation of authentic antibody signals 
caused by incubation at pH 2.5
One possibility is that both the artifactual signal caused by
low pH incubation (process A) and the inactivation of
authentic anti-Aβ signals (process B) were due to exces-
sively low pH during the incubation. Thus, we compared
pH 2.5 with a slightly less aggressive incubation at pH 3.5.
In normal sera collected from nonTg unvaccinated mice
we found that pH 2.5 increased the apparent anti-Aβ
ELISA signal, but incubation at pH 3.5 did not (fig 6A).
Conversely, when sera from vaccinated nonTg mice were
evaluated, incubation at pH 2.5 caused inactivation of the
anti-sera raised against human Aβ 1–42 peptide (figure
5B), however, incubation at pH at 3.5 did not result in
loss of anti-Aβ signal (fig 6B). Thus, neither process A not
process B is apparent after incubation at pH 3.5
Incubation at pH 3.5 rather than 2.5 can dissociate antigen 
antibody complexes without causing induction of 
artifactual signals or denaturing authentic anti-Aβ 
antibodies
To determine whether low pH does effectively unmask the
anti-Aβ antibodies from Aβ (process C), we first incubated
either a monoclonal antibody (fig 7A) or sera from vacci-
nated nonTg mice (fig 7B) with 0 or 1 μg/ml Aβ to form
antigen-antibody complexes. We then subjected the sam-
ples to incubation at either a) pH 7.0, b) pH 2.5 or c) pH
3.5 and performed ELISA assays coating the plate with
human Aβ1–42. Figure 7. shows that the ELISA signals of
both authentic antibodies were dramatically reduced
when antigen-antibody complexes were formed by mix-
ing with 1 μg/ml Aβ and incubated at pH 7.0 (left pair of
bars in 7A and 7B). Incubation at pH 2.5 (center pair of
bars) had two effects; a reduction in signal intensity in the
absence of antibody-antigen formation (open bars), and
an increase in signal intensity when antigen antibody
complexes were formed (solid bars) compared to pH 7
incubation. Importantly changing the low pH incubation
to pH 3.5 avoids both issues. There is no apparent inacti-
vation of antibody at this pH (compare open bars at pH 7
and pH 3.5) and a complete restoration of the ELISA sig-
Incubation at pH 2.5 induced artifactual ELISA signal appears to be IgG associated Figure 2
Incubation at pH 2.5 induced artifactual ELISA signal appears to be IgG associated. Panel 2A. Normal sera were collected from 
nonTg unvaccinated mice, diluted 1:400 and preincubated at either pH 7 (open bars) or pH 2.5 (solid bars) as described in 
methods. After centrifugation, neutralization and reconstitution of sera volume, the sera were incubated on the ELISA plates 
coated with human Aβ1–42 for 60 minutes. After washing the plate, anti-mouse gamma chain specific (left) or anti-mouse 
whole IgG (right) were pipetted into the different wells of plate. Panel 2B. Normal sera from nonTg unvaccinated mice were 
incubated at pH 7.0 (open bars) or pH 2.5 (solid bars) and then IgG was purified with protein A/G (Pierce) as described in 
methods. Protein was measured with BCA protein assay Kit (Pierce), and dilutions of the purified IgG were incubated as the 
indicated concentrations on ELISA plates coated with Aβ1–42. ELISA assays were completed as described in methods. ** P < 
0.001 compared to pH 7.0.
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nal when antibody-antigen complexes were formed (solid
bar equals open bar at pH 3.5. In other work, we have not
observed any artifactual increase in ELISA signal when
sera from unvaccinated mice are incubated at pH 3.5 (data
not shown).
Discussion and conclusion
Previously, we reported that using a low pH dissociation
procedure in vaccinated APP transgenic mice, anti-Aβ
antibody titers increased considerably, consistent with an
apparent unmasking of antibody binding sites occluded
by bound antigen [5]. Unexpectedly, we subsequently
found that this low pH incubation of normal sera col-
lected from nonTg, unvaccinated mice also showed an
similar increase in ELISA signals when human Aβ1–42
was used to coat the ELISA plate. Moreover, this increased
signal was not observed to the same extent with other pep-
tides including bovine serum albumin, alpha-synuclein
protein, truncated Aβ11–20 and phosphate buffer saline
(figure 1B). Our initial interpretation was that the
untreated mouse may have anti-Aβ antibodies which were
normally occluded in serum by endogenous murine Aβ.
While this seemed surprising given that there was no rea-
son to expect untreated mice to have either anti-Aβ anti-
bodies, nor sufficient concentrations of circulating Aβ to
occlude them, it was consistent with the observations we
had up to that time. We also confirmed that the protein in
serum that was responsible for the increased ELISA signal
after low pH incubation was IgG by using more selective
antibodies as reporters, and demonstrating that the
increased Aβ binding was retained when IgG was purified
from serum using protein A/G columns (Fig 2). Moreover
Duration of pH 2.5 exposure differentially affects ELISA signals in sera from unvaccinated nonTg mice compared to vaccinated  nonTg mice Figure 3
Duration of pH 2.5 exposure differentially affects ELISA signals in sera from unvaccinated nonTg mice compared to vaccinated 
nonTg mice. Sera were collected from unvaccinated mice (3A) and mice vaccinated with human Aβ1–42 peptide (3B), diluted 
1:400. Aliquots were incubated with dissociation buffer at pH 7 (open bar, 120 min) or pH 2.5 (solid bars) for 5, 20, 30, 90 and 
120 minutes. The ELISA assays were completed as described in methods and the optical density at 450 nm used to estimate the 
amount of antibody binding to the ELISA plate. Results are presented as mean ± SEM. * P < 0.05; ** P < 0.001 compared to pH 
7.0.
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Incubation at pH 2.5 induced artifactual ELISA signal only interacts with full length Aβ; Authentic antibodies bind both full  length Aβ and N terminal fragments Figure 4
Incubation at pH 2.5 induced artifactual ELISA signal only interacts with full length Aβ; Authentic antibodies bind both full 
length Aβ and N terminal fragments. Epitope mapping of normal sera from unvaccinated mice (panel A;1:400 dilution), mice 
vaccinated with Aβ1–42 peptide (panel B; 1:400 dilution) or mouse anti-human Aβ1–16 monoclonal antibody (6E10; 4C;50 ng/
ml) was performed. Full length human Aβ and human Aβ fragments (singly and in combination as indicated on graph) were used 
to coat the plate and identify the domain that interacted with the IgG fractions following pH 7 preincubation (full length Aβ 
only) or incubation at pH 2.5 for 20 minutes at RT. After centrifugation and neutralization the samples were then incubated on 
ELISA plates coated as indicated. Values are mean ± SEM. ** P < 0.001 compared to pH 2.5 plate coated with Aβ1–42 peptide.
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cross reaction between mouse and human Aβ seemed fea-
sible as Takeshi Kawarabayashi et al [12]showed that
BNT-77, a monoclonal antibody against human Aβ11–28
could bind mouse Aβ in nonTg animals.
The interpretation that the increased ELISA signal caused
by low pH incubation was due to endogenous murine
anti-Aβ antibodies was challenged by differences in the
behavior of this signal from untreated mice compared to
that found after vaccinating nonTg mice against the Aβ
peptide to generate authentic anti-Aβ antibodies. First, we
observed that unlike the circumstance in transgenic mice,
sera from nonTg mice vaccinated against Aβ actually lost
apparent ELISA signal against Aβ when incubated at pH
2.5 (fig 3B). Epitope mapping studies found that the
authentic anti-Aβ antibodies produced by vaccination
bound Aβ1–16 in largely the same manner as full length
Aβ, whereas, the acid-induced ELISA signal only could be
detected when full length Aβ was bound to the ELISA
plate (fig 4). The behavior of a monoclonal murine anti-
Aβ antibody (6E10) was quite similar to the immune
serum, and not the normal serum. A final inconsistency
was the affinity for the Aβ peptide. Aβ at 1 μg/ml, the low-
est concentration tested, largely eliminated the ELISA sig-
nal obtained with sera from vaccinated mice. However,
even doses 100 fold greater, had little ability to block the
increased ELISA signal found with untreated sera when
incubated at pH 2.5.
Thus, whatever is responsible for the increased anti-Aβ
ELISA signal found in untreated nonTg mouse serum, it
has very low affinity for Aβ, and is somehow dependent
upon the presence of the entire peptide to exhibit binding
behavior. Given the low affinity of Aβ binding in pH 2.5
treated normal mouse serum, only serum Aβ concentra-
tions that exceeded 100 μg/ml (25 μM concentration)
would be able to mask the antibody. Given that the circu-
lating Aβ concentration in APP overexpressing transgenic
mice is 0.5 to 5 nM, it would seem this concentration is
unlikely ever to occur in nonTg mice. A final argument
against this hypothesis is that the nonTg mice vaccinated
against Aβ do not appear to have antibody masking. Not
only does the low pH fail to reveal occluded binding sites
in the ELISA, there is an apparent time dependent inacti-
vation of these authentic anti-Aβ antibodies caused by the
pH 2.5 incubation. Thus we conclude that pH 2.5 incuba-
tion causes a low affinity interaction with full length Aβ
that is artifactual, and unlikely to represent unmasking of
authentic anti Aβ antibodies. We have referred to this as
process A in the results section.
Incubation at pH 2.5 induced artifactual ELISA signal has a lower affinity for Aβ than authentic anti-Aβ antibodies in competi- tion assays Figure 5
Incubation at pH 2.5 induced artifactual ELISA signal has a lower affinity for Aβ than authentic anti-Aβ antibodies in competi-
tion assays. Sera from unvaccinated mice (panel A) or mice vaccinated with Aβ 1–42 peptide (panel B), were diluted 1:1000 and 
preincubated at either pH 7 or pH 2.5. After centrifugation, neutralization and reconstitution of sera volume, the sera were 
then incubated with human Aβ1–42 peptide, at increasing concentrations at 37°C for 60 minutes. Because the Aβ was initially 
dissolved in DMSO, some samples were also incubated with 2% DMSO as control. The ELISA assay was then performed as 
described in methods with no further separation of Aβ and antibody fractions. ** P < 0.001 compared to pH 2.5 without Aβ 
preincubation.
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One possibility is the IgG responsible for the apparent
anti-Aβ ELISA signal enhanced by low pH are natural
polyreactive autoantibodies [13,14] which recognize sev-
eral structurally unrelated epitopes, or relatively nonselec-
tive antibodies that recognize Aβ and a large number of
similar peptide sequences with low affinity. These may be
occluded by antigens other than Aβ, and become available
for binding in the ELISA assays due to unmasking. How-
Incubation of sera at pH 3.5 does not induce artifactual ELISA signals nor inactivate authentic anti-Aβ antibody binding in ELISA  assay Figure 6
Incubation of sera at pH 3.5 does not induce artifactual ELISA signals nor inactivate authentic anti-Aβ antibody binding in ELISA 
assay. Sera collected from unvaccinated mice (6A) and mice vaccinated with Aβ 1–42 peptide (6B) were incubated with disso-
ciation buffer at pH 7.0 (open bars), 3.5 (grid bars) or 2.5 (solid bars) for 20 minutes, separated by centrifugation through 
10,000 MW filters neutralized and reconstituted to original volume. They were then incubated in a standard ELISA assay using 
full length Aβ to coat the plate. * P < 0.05 compared to pH 7.0; ** P < 0.001 compared to pH 7.0.
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Dissociation of Aβ-IgG immune complexes occurs at both pH 2.5 and pH 3.5 Figure 7
Dissociation of Aβ-IgG immune complexes occurs at both pH 2.5 and pH 3.5. Mouse anti-human Aβ1–16 monoclonal antibody 
(6E10) at 10 μg/ml (7A) and serum from mice vaccinated with Aβ diluted 1:100 were preincubated with Aβ1–42 peptide at 1 
μg/ml to form antigen-antibody complexes (solid bars) or preincubated with PBS as a control (open bars) at 37°C for 60 min-
utes. Aliquots from each sample were then incubated with a 10-fold larger volume (1:1000 final serum dilution in panel B) of 
dissociation buffer at pH 7, pH 2.5 and pH 3.5, respectively, for 20 minutes, separated by centrifugation through 10,000 MW fil-
ters, neutralized and reconstituted to original volume for standard ELISA assay with full length human Aβ coating the plate.
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ever, our most favored interpretation is that the low pH
partially denatures the antibodies, revealing hydrophobic
residues typically shielded from interaction by their inter-
nalized location. These residues may then interact with
other hydrophobic domains, such as found on the full
length Aβ peptide, with low affinity but high capacity,
since many IgG molecules may be susceptible to this
denaturation. Such denaturation may similarly account
for the loss of authentic anti-Aβ activity caused by low pH
treatment of sera from vaccinated mice, the inactivation
response we referred to as process B in the results.
Fortunately, the use of a less stringent method of dissoci-
ating antigen-antibody complexes can unmask occluded
antibodies without a) artifactually increasing anti-Aβ
ELISA signal or b) inactivating authentic anti-Aβ antibod-
ies. Incubating at pH 3.5 instead of pH 2.5 largely elimi-
nates the problems reported here in the acid dissociation
procedure (fig 6). After spiking a serum sample with Aβ
and preincubating to form antigen-antibody complexes,
we observed significant loss of ELISA signal when sera
were subsequently treated in a normal manner at neutral
pH. However, incubating spiked sera at pH 3.5 restored
the ELISA titer values to those found in the absence of
added exogenous Aβ peptide (fig 7).
In our prior work (5), we now believe these three phe-
nomena were occurring simultaneously to produce the
data we observed. All of this prior work used APP trans-
genic mice, which would be expected to have high con-
centrations of circulating Aβ to bind to anti-Aβ antibodies
(most of the work reported here used nonTg mice). We
suspect that in addition to unmasking (process C) there
were counteracting influences of authentic antibody inac-
tivation (process B) and artifactual increases in ELISA sig-
nals (process A). in the initial work, although all three
processes were active, the unmasking dominated when
evaluating vaccinated APP transgenic mice that had high
levels of both authentic antibodies and high levels of cir-
culating Aβ. Only when we examined normal serum from
unvaccinated nonTg mice did we reveal process A (an arti-
fact) and only when we examined serum from vaccinated
transgenic mice did we observe inactivation (process B).
While we are confident that antibody masking was occur-
ring in our earlier work and the data are accurate, our own
subsequent work and reports from our colleagues indi-
cated that pH 2.5 incubations were doing more than sim-
ply dissociating antigen-antibody complexes. Therefore
we feel it important to report his improvement to our ear-
lier technique so that others do not suffer through the
same trials we have in understanding the complexities
involved.
In conclusion, dissociation of antigen-antibody com-
plexes is an important step in evaluating the anti-Aβ anti-
body titers in serum from APP transgenic mice, and most
likely in human sera as well. This is most significant when
the anti-Aβ antibody titers are low, as high titers result in
excess antibody relative to Aβ peptide. Incubations at pH
2.5 cause both spurious increases in ELISA signals that are
not due to high affinity anti-Aβ antibodies, and partially
inactivate the ELISA signals resulting from authentic high
affinity anti-Aβ antibodies probably due to denaturation.
While both artifactual signals and antibody inactivation
are absent at pH 3.5, antigen-antibody unmasking still
occurs. This improved assay should be valuable in accu-
rately assessing anti-Aβ antibody titers in transgenic mice
and in humans treated with immunotherapy.
Methods
Vaccination protocols
The Tg2576 APP transgenic mice [15] and nonTg litterma-
tes were produced as described previously and have been
bred continuously for over 10 years in our colony [16].
NonTg mice from this breeding were vaccinated with
human Aβ1–42 peptide (American peptide) as described
previously [2]. Briefly, Aβ Peptide was suspended in pyro-
gen-free Type I water at 2.2 mg/ml then mixed with 10×
PBS to yield 1× PBS solution and incubated overnight at
37°C. The following day, two volumes of 1× PBS was
added to dilute the Aβ peptide further, and then the pep-
tide suspension was emulsified with an equal volume of
Freund's complete adjuvant (Sigma). The vaccine prepara-
tion (100 μg Aβ/300 μl volume) was injected into each
mouse subcutaneously. For the second immunization, the
same materials were prepared freshly in incomplete Fre-
und's adjuvant (Sigma) at 14 days after first injection. The
third and fourth boosts were made incomplete Freund's at
monthly intervals after the second immunization. Mice
were vaccinated beginning at 9 months of age and sacri-
ficed at 12 months of age, 14 days after the fourth inocu-
lation.
Dissociation of anti-Aβ antibody from Aβ in serum
Sera were diluted 1:100 with dissociation buffer (PBS
buffer with 1.5% BSA and 0.2 M glycine-acetate), pH 2.5
and/or pH 3.5 to a 500 ul final volume and incubated for
20 min. at room temperature (RT). The sera were then
pipetted into the sample reservoir of Microcon centrifugal
filter device, YM-10 (10,000 MW cut-off; Millipore) and
centrifuged at 8,000× g for 20 min. at RT. The sample res-
ervoir was then separated from the flow through, placed
inverted into a second tube and centrifuged at 1000 × g for
3 min. at RT. The collected solution containing the anti-
body dissociated from the Aβ peptide was adjusted to pH
7.0 with 1 M Tris buffer, pH 9.0. The retentate volume was
reconstituted to the initial volume (500 μl) with ELISA
dilution buffer (PBS with 1.5% BSA and 0.1% Tween-20).
The collected sera were then added to an ELISA plate at
several dilutions to determine the antibody titer. As con-BMC Neuroscience 2007, 8:22 http://www.biomedcentral.com/1471-2202/8/22
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trol, the same serum was treated with identical process
except using dissociation buffer, pH 7.0 instead of disso-
ciation buffer, pH 2.5.
Purification of IgG from mouse sera
The sera were pooled from four nonTg unvaccinated mice,
500 μl was added to 2 ml dissociated buffer at pH 2.5 or
pH 7.0 respectively, incubated 20 minutes at room tem-
perature then neutralized with 1 M Tri/HCL pH9.0 (pH
2.5 samples). The samples were mixed with an equal vol-
ume binding buffer (provided by ImmunoPure (A/G) IgG
purification Kit, PIERCE 44902, Rockford IL USA) and
then IgG were collected according to the instructions.
Briefly, the diluted samples were applied to the Protein A/
G Columns. After washing the Protein A/G columns with
binding buffer, the IgG captured by the Protein A/G Col-
umns were eluted by elution buffer followed by collection
of successive 1 ml fractions. The eluted fractions were
immediately adjusted to physiologic pH by adding 100 μl
of 1 M Tris pH 9.0 to 1 ml of eluate and then the proce-
dure for buffer exchange (desalting) was applied with 5
ml D-salt Dextran Desalting Columns. The purified IgG
were measured by BCA Protein Assay Kit (PIERCE 23227).
Measurements of antibody titers by ELISA
Ninety-six-well Immulon 4HBX plates (Dynex) were
coated with 50 μl per well of human Aβ1–42 peptide 5 μg/
ml in PBS buffer, pH 7.0 and incubated overnight at 4°C.
The plates were washed five times with 0.45%
NaCl+0.05% Tween-20 (washing buffer, WB) and
blocked at 37°C for 1 hour with blocking buffer (1.5%
BSA and 0.05% Tween-20 in PBS). After five washes with
WB, the sera were added to the plates in duplicate and
incubated for 1 hour at 37°C. The plates were washed 10
times and anti-mouse IgG conjugated with horseradish
peroxidase (HRP) (Sigma Chemical Co. St. Louis, MO)
diluted 1:5000 was added to the plates and incubated for
1 hour at 37°C. The plates were then washed ten times
and developed with (3', 3', 5', 5'-Tetramethylbenzidine)
TMB (Sigma). The reaction was stopped with 2 M sulphu-
ric acid. The plates were analyzed spectrophotometrically
at 450 nm.
Statistical analysis
Data were analyzed by one-way analyses of variance
(ANOVA), followed by Fisher's least significance differ-
ence means comparisons using StatView (SAS institute).
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